Awards for “mckesson”
25 awards on this page · sorted by amount · page 3
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| 36C24023K1005 | MCKESSON CORPORATION | Department of Veterans Affairs | $688.57M | 2023-02-01 | 2023-02-28 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 FEBRUARY |
| 36C24021K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | $681.53M | 2021-08-01 | 2021-08-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 AUGUST |
| 36C24022K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | $675.96M | 2022-04-01 | 2022-04-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 APRIL |
| 36C24023K1002 | MCKESSON CORPORATION | Department of Veterans Affairs | $675.5M | 2022-11-01 | 2022-11-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 NOVEMBER |
| 36C24022K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | $671.82M | 2022-05-01 | 2022-05-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 MAY |
| 36C24023K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | $660.05M | 2022-10-01 | 2022-10-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 OCTOBER |
| 36C24025K1003 | MCKESSON CORPORATION | Department of Veterans Affairs | $659.11M | 2024-12-01 | 2024-12-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 DECEMBER |
| 36C24021K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | $658.33M | 2021-03-01 | 2021-03-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 MARCH |
| 36C24021K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | $654.78M | 2021-06-01 | 2021-06-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 JUNE |
| 36C24022K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | $651.38M | 2022-01-01 | 2022-01-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 JANUARY |
| 36C24021K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | $638.82M | 2021-07-01 | 2021-07-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 JULY |
| 36C24025K1005 | MCKESSON CORPORATION | Department of Veterans Affairs | $633.61M | 2025-02-01 | 2025-02-28 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 FEBRUARY |
| 36C24024K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | $620.87M | 2024-05-01 | 2024-05-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MAY |
| 36C24021K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | $618.75M | 2021-04-01 | 2021-04-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 APRIL |
| 36C24024K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | $610.15M | 2024-04-01 | 2024-04-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 APRIL |
| 36C24022K1003 | MCKESSON CORPORATION | Department of Veterans Affairs | $609.01M | 2021-12-01 | 2021-12-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 DECEMBER |
| 36C24024K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | $608.69M | 2024-01-01 | 2024-01-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JANUARY |
| 36C24022K1005 | MCKESSON CORPORATION | Department of Veterans Affairs | $599.94M | 2022-02-01 | 2022-02-28 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 FEBRUARY |
| 36C24021K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | $585.52M | 2020-10-01 | 2020-10-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 OCTOBER |
| 36C24022K1002 | MCKESSON CORPORATION | Department of Veterans Affairs | $585.2M | 2021-11-01 | 2021-11-30 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 NOVEMBER |
| 36C24021K1003 | MCKESSON CORPORATION | Department of Veterans Affairs | $584.54M | 2020-12-01 | 2020-12-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 DECEMBER |
| 36C24022K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | $582.33M | 2021-10-01 | 2021-10-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2022 OCTOBER |
| 36C24021K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | $575.52M | 2021-05-01 | 2021-05-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 MAY |
| 36C24024K1005 | MCKESSON CORPORATION | Department of Veterans Affairs | $567.91M | 2024-02-01 | 2024-02-29 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 FEBRUARY |
| 36C24024K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | $559.37M | 2023-10-01 | 2023-10-31 | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 OCTOBER |